Literature DB >> 16146852

Fatal primary Epstein-Barr virus infection due to clonal CD8+ T-lymphocyte proliferation in an immunocompetent adult.

Naoko Satoh1, Tadashi Koike, Hidekichi Takato, Masahiro Fujiwara, Iwao Emura, Hirokazu Kaneganed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16146852     DOI： 10.1532/IJH97.04194

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

Review 1.  Epstein-Barr virus infection.

Authors:  J I Cohen
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

2.  Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis.

Authors:  M Yagita; H Iwakura; T Kishimoto; T Okamura; A Kunitomi; R Tabata; Y Konaka; K Kawa
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 3.  Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.

Authors:  Akihiro Yachie; Hirokazu Kanegane; Yoshihito Kasahara
Journal:  Semin Hematol       Date:  2003-04       Impact factor: 3.851

4.  SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.

Authors:  R Sumazaki; H Kanegane; M Osaki; T Fukushima; M Tsuchida; H Matsukura; K Shinozaki; H Kimura; A Matsui; T Miyawaki
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

6.  Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

Authors:  Y Kasahara; A Yachie; K Takei; C Kanegane; K Okada; K Ohta; H Seki; N Igarashi; K Maruhashi; K Katayama; E Katoh; G Terao; Y Sakiyama; S Koizumi
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

7.  Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.

Authors:  M Arico; S Imashuku; R Clementi; S Hibi; T Teramura; C Danesino; D A Haber; K E Nichols
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

8.  Infection of human thymocytes by Epstein-Barr virus.

Authors:  D Watry; J A Hedrick; S Siervo; G Rhodes; J J Lamberti; J D Lambris; C D Tsoukas
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

9.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.

Authors:  J Sayos; C Wu; M Morra; N Wang; X Zhang; D Allen; S van Schaik; L Notarangelo; R Geha; M G Roncarolo; H Oettgen; J E De Vries; G Aversa; C Terhorst
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962
  9 in total
  1 in total

1.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.